Merck Wants to Extend RSV Vaccine to Second Season
FDA will review Enflonsia's ability to protect high-risk children under 2 years of age during their second RSV season.
FDA will review Enflonsia's ability to protect high-risk children under 2 years of age during their second RSV season.
UCLA Health combines biopsy, staging, and surgery into a single session to reduce delays and improve lung cancer patient outcomes.
The American Lung Association’s 2023 "State of Lung Cancer" report reveals improvement in five-year survival rate across the US, including for people of color.
California is launching a statewide initiative to provide free albuterol inhalers and spacers to 10,000 public and charter schools to treat students during respiratory emergencies, according to Governor Gavin Newsom.
A national study finds significant inconsistency among doctors when interpreting lung sounds in children suspected of pediatric pneumonia.
Research highlights significant delays in the transition from emergency care to inpatient management for admitted patients.
A study of more than 14,000 lung cancer patients suggests age influences tumor biology and the availability of targeted therapy options.
Secondhand tobacco smoke increased sleep interruptions in pediatric patients, even when traditional apnea measures remain unchanged.